AI assistant
GEORGIA CAPITAL PLC Remuneration Information 2021
5002_def-14a_2021-06-30_86b70e73-9c3b-4895-bbe1-d6f06be0e5b6.html
Remuneration Information
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information 
RNS Number : 7304D
Georgia Capital PLC
30 June 2021
London, 30 June 2021
NOTIFICATION OF TRANSACTIONS OF DIRECTORS/PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY AND CONNECTED PERSONS
The notification set out below is provided in accordance with the requirements of the EU Market Abuse Regulation.
1.
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Irakli Gilauri
2.
Reason for the notification
a)
Position / status
PDMR, CEO and Chairman
b)
Initial notification / amendment
Initial notification
3.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Georgia Capital PLC
b)
LEI:
213800Q65T5GNBOW7H65
4.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification Code
Nil cost options over ordinary shares of £0.01 each in Georgia Capital PLC
N/A
b)
Nature of the transaction
Grant of nil-cost options over ordinary shares in respect of discretionary deferred salary shares for the 2020 work year pursuant to the executive equity compensation plan.
25% of the salary shares will vest in each of the second, third, fourth and fifth years following the work year, subject to the terms of his service agreement.
c)
Price(s) and volume(s)
| Price(s) | Volume(s) |
| n/a | 160,000 |
d)
Aggregated information
Aggregated volume
Grant of 160,000 nil-cost options over ordinary shares in respect of discretionary deferred shares for the 2020 work year pursuant to the executive equity compensation plan. Vesting will not begin until 2022.
Aggregated price
n/a
e)
Dates of the transaction
29 June 2021
f)
Place of the transaction
Outside of a trading venue
1.
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Avtandil Namicheishvili
2.
Reason for the notification
a)
Position / status
PDMR, Deputy CEO
b)
Initial notification / amendment
Initial notification
3.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Georgia Capital PLC
b)
LEI:
213800Q65T5GNBOW7H65
4.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification Code
Nil cost options over ordinary shares of £0.01 each in Georgia Capital PLC
N/A
b)
Nature of the transaction
Grant of nil-cost options over ordinary shares in respect of deferred salary shares for the 2020 work year pursuant to the executive equity compensation plan.
25% of the salary shares will vest in each of the second, third, fourth and fifth years following the work year, subject to the terms of his service agreement.
c)
Price(s) and volume(s)
| Price(s) | Volume(s) |
| n/a | 108,000 |
d)
Aggregated information
Aggregated volume
Grant of 108,000 nil-cost options over ordinary shares in respect of deferred salary shares for the 2020 work year pursuant to the executive equity compensation plan. Vesting will not begin until 2022.
Aggregated price
n/a
e)
Dates of the transaction
29 June 2021
f)
Place of the transaction
Outside of a trading venue
1.
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Giorgi Alpaidze
2.
Reason for the notification
a)
Position / status
PDMR, CFO
b)
Initial notification / amendment
Initial notification
3.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Georgia Capital PLC
b)
LEI:
213800Q65T5GNBOW7H65
4.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification Code
Nil cost options over ordinary shares of £0.01 each in Georgia Capital PLC
N/A
b)
Nature of the transaction
Grant of nil-cost options over ordinary shares in respect of deferred salary shares for the 2020 work year pursuant to the executive equity compensation plan.
33.3% of the salary shares will vest in each of the second, third and fourth years following the work year, subject to the terms of his service agreement.
c)
Price(s) and volume(s)
| Price(s) | Volume(s) |
| n/a | 80,434 |
d)
Aggregated information
Aggregated volume
Grant of 80,434 nil-cost options over ordinary shares in respect of deferred salary shares for the 2020 work year pursuant to the executive equity compensation plan. Vesting will not begin until 2022.
Aggregated price
n/a
e)
Dates of the transaction
29 June 2021
f)
Place of the transaction
Outside of a trading venue
1.
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Nikoloz Gamkrelidze
2.
Reason for the notification
a)
Position / status
PDMR, CEO of Georgia Healthcare Group
b)
Initial notification / amendment
Initial notification
3.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Georgia Capital PLC
b)
LEI:
213800Q65T5GNBOW7H65
4.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification Code
Nil cost options over ordinary shares of £0.01 each in Georgia Capital PLC
N/A
b)
Nature of the transaction
Grant of nil-cost options over ordinary shares in respect of deferred salary shares for the 2020 work year pursuant to the executive equity compensation plan.
33.3% of the salary shares will vest in each of the second, third and fourth, years following the work year, subject to the terms of his service agreement.
c)
Price(s) and volume(s)
| Price(s) | Volume(s) |
| n/a | 159,572 |
d)
Aggregated information
Aggregated volume
Grant of 159,572 nil-cost options over ordinary shares in respect of deferred salary shares for the 2020 work year pursuant to the executive equity compensation plan. Vesting will not begin until 2022.
Aggregated price
n/a
e)
Dates of the transaction
29 June 2021
f)
Place of the transaction
Outside of a trading venue
1.
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Nikoloz Gamkrelidze
2.
Reason for the notification
a)
Position / status
PDMR, CEO of Georgia Healthcare Group
b)
Initial notification / amendment
Initial notification
3.
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Georgia Capital PLC
b)
LEI:
213800Q65T5GNBOW7H65
4.
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification Code
Nil cost options over ordinary shares of £0.01 each in Georgia Capital PLC
N/A
b)
Nature of the transaction
Grant of nil-cost options over ordinary shares in respect of discretionary deferred shares for the 2020 work year pursuant to the executive equity compensation plan.
25% of the salary shares will vest in each of the second, third, fourth and fifth years following the work year, subject to the terms of his service agreement.
c)
Price(s) and volume(s)
| Price(s) | Volume(s) |
| n/a | 35,000 |
d)
Aggregated information
Aggregated volume
Grant of 35,000 nil-cost options over ordinary shares in respect of discretionary deferred shares for the 2020 work year pursuant to the executive equity compensation plan. Vesting will not begin until 2022.
Aggregated price
n/a
e)
Dates of the transaction
29 June 2021
f)
Place of the transaction
Outside of a trading venue
Name of authorised official of issuer responsible for making notification:
Link Company Matters, Company Secretary
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHQBLFXFQLFBBZ